This Viewpoint discusses why the market for biosimilars and the cost savings related to their use have remained smaller than expected in the United States and suggests ways to rectify this situation.
http://ift.tt/2sYaYsF
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
-
http://ift.tt/2sxENoo
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου